Cryotherapy for Barrett's Esophagus and Early Esophageal Cancers
NCT00650988 is a phase early 1 interventional trial sponsored by Case Comprehensive Cancer Center. As of 21 Nov 2026, it is completed. It studies Barretts Esophagus and Esophageal Cancer. The registry lists an enrollment of 37 participants at 1 site in 1 country. The registry lists a start date of 30 Sept 2005 and a primary completion date of 31 May 2008.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT00650988 |
| Status | Completed |
| Phase | Phase Early 1 |
| Study type | Interventional trial |
| Lead sponsor | Case Comprehensive Cancer Center |
| Enrollment | 37 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Barretts Esophagus and Esophageal Cancer |
| Start | 30 Sept 2005 |
| Primary completion | 31 May 2008 |
| Study completion | 31 Dec 2008 |
| Last update posted | 24 Dec 2012 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- John A. Dumot, D.O.
The Cleveland Clinic
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Cleveland Clinic
Cleveland
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT00650988
Each answer restates registry values shown on this page.
What is NCT00650988?
NCT00650988 is a phase early 1 interventional trial sponsored by Case Comprehensive Cancer Center. It studies Barretts Esophagus and Esophageal Cancer.
Who leads NCT00650988?
The registry names John A. Dumot, D.O. (principal investigator, The Cleveland Clinic) as the overall official.
Where does NCT00650988 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT00650988 end?
The registry lists a primary completion date of 31 May 2008 and a study completion date of 31 Dec 2008. The sponsor last updated the record on 24 Dec 2012.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.